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Evidence maps of research and of existing and 
emerging applications 
 
The evidence maps were generated in the project DEEPEN GENOMICS (“Opportunities and 
challenges of the convergence of artificial intelligence, human genomics and genome editing”). The 
project (https://www.itas.kit.edu/english/projects_koen19_deepgen.php) ran from January 2019 until 
December 2020 and was funded within the framework "Innovations- und Technikanalyse” (Innovation 
and Technology Analysis), ITA of Germany’s Federal Ministry of Education and Research, BMBF 
(https://www.bmbf.de/de/ita-vorhaben-10103.html). 
 
The maps were developed to examine and present in an evidence-based manner (i.e., based on peer-
reviewed scientific publications, conference papers/proceedings or patents) the current state of 
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Editas - Functional data from genome-wide 
genome editing screens (e.g.,  [1] and 
refs. therein) 
- Design of Genome editing tools by DL 
(gRNA) [9-11] 

















- Improvement (by conv. ML) of 
polygenic risk scores (based on 
GWAS) [2-5] 
- Interaction of SNPs from GWAS 
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- DL-Prediction of variant effects on 
intermediate cellular processes [6-
8] 
- Identification / prediction of 
causal (functional) variants for 
diseases by DL [7, 8, 12-17] 
- Identification / prediction of 
driver mutations in cancer, conv. 
ML and DL  [20-23] (also NGS data on 
liquid biopsies by DL  [25], data from 
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(i.e., not yet supported by studies) 
Companies that already use 
corresponding approaches 
- DL for predicting the biological 
activities of drug candidates toward 
target proteins of interest (virtual 
screening, QSAR): ligand-based [27, 
28] and structure- based [29] 
- DL (incl. GAN) for predicting drug 
activity of molecules and for de novo 
drug design [30-35] 
- DL-based protein structure 
prediction [36, 37] and protein  (drug) 
design [38, 39] 





















1. Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K.R., MacLeod, G., Mis, M., 
Zimmermann, M., Fradet-Turcotte, A., Sun, S., et al. (2015). High-Resolution CRISPR Screens Reveal 
Fitness Genes and Genotype-Specific Cancer Liabilities. Cell 163, 1515-1526. 
2. Khera, A.V., Chaffin, M., Aragam, K.G., Haas, M.E., Roselli, C., Choi, S.H., Natarajan, P., Lander, E.S., 
Lubitz, S.A., Ellinor, P.T., et al. (2018). Genome-wide polygenic scores for common diseases identify 
individuals with risk equivalent to monogenic mutations. Nat Genet 50, 1219–1224  
3. So, H.C., and Sham, P.C. (2017). Improving polygenic risk prediction from summary statistics by an 
empirical Bayes approach. Sci Rep-Uk 7. 
4. Paré, G., Mao, S., and Deng, W.Q. (2017). A machine-learning heuristic to improve gene score 
prediction of polygenic traits. Sci Rep-Uk 7, 12665. 
5. Lello, L., Raben, T.G., Yong, S.Y., Tellier, L., and Hsu, S.D.H. (2019). Genomic Prediction of 16 
Complex Disease Risks Including Heart Attack, Diabetes, Breast and Prostate Cancer. Sci Rep 9, 
15286. 
6. Alipanahi, B., Delong, A., Weirauch, M.T., and Frey, B.J. (2015). Predicting the sequence specificities of 
DNA- and RNA-binding proteins by deep learning. Nat Biotechnol 33, 831-+. 
7. Xiong, H.Y., Alipanahi, B., Lee, L.J., Bretschneider, H., Merico, D., Yuen, R.K.C., Hua, Y.M., 
Gueroussov, S., Najafabadi, H.S., Hughes, T.R., et al. (2015). The human splicing code reveals new 
insights into the genetic determinants of disease. Science 347. 
8. Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J.F., Darbandi, S.F., Knowles, D., Li, Y.I., 
Kosmicki, J.A., Arbelaez, J., Cui, W., Schwartz, G.B., et al. (2019). Predicting Splicing from Primary 
Sequence with Deep Learning. Cell 176, 535-548 e524. 
9. Listgarten, J., Weinstein, M., Kleinstiver, B.P., Sousa, A.A., Joung, J.K., Crawford, J., Gao, K., Hoang, 
L., Elibol, M., and Doench, J.G. (2018). Prediction of off-target activities for the end-to-end design of 
CRISPR guide RNAs. Nature Biomedical Engineering 2, 38. 
10. Kim, H.K., Min, S., Song, M., Jung, S., Choi, J.W., Kim, Y., Lee, S., Yoon, S., and Kim, H.H. (2018). 
Deep learning improves prediction of CRISPR–Cpf1 guide RNA activity. Nat Biotechnol 36, 239. 
11. Wang, D., Zhang, C., Wang, B., Li, B., Wang, Q., Liu, D., Wang, H., Zhou, Y., Shi, L., Lan, F., et al. 
(2019). Optimized CRISPR guide RNA design for two high-fidelity Cas9 variants by deep learning. Nat 
Commun 10, 4284. 
12. Zhou, J., and Troyanskaya, O.G. (2015). Predicting effects of noncoding variants with deep learning-
based sequence model. Nat Methods 12, 931-934. 
13. Zhou, J., Theesfeld, C.L., Yao, K., Chen, K.M., Wong, A.K., and Troyanskaya, O.G. (2018). Deep 
learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat Genet 
50, 1171-1179. 
14. Yao, V., Kaletsky, R., Keyes, W., Mor, D.E., Wong, A.K., Sohrabi, S., Murphy, C.T., and Troyanskaya, 
O.G. (2018). An integrative tissue-network approach to identify and test human disease genes. Nat 
Biotechnol 36, 1091–1099. 
15. Krishnan, A., Zhang, R., Yao, V., Theesfeld, C.L., Wong, A.K., Tadych, A., Volfovsky, N., Packer, A., 
Lash, A., and Troyanskaya, O.G. (2016). Genome-wide prediction and functional characterization of the 
genetic basis of autism spectrum disorder. Nat Neurosci 19, 1454-1462. 
16. Wang, D., Liu, S., Warrell, J., Won, H., Shi, X., Navarro, F.C.P., Clarke, D., Gu, M., Emani, P., Yang, 
Y.T., et al. (2018). Comprehensive functional genomic resource and integrative model for the human 
brain. Science 362. 
17. Zhou, J., Park, C.Y., Theesfeld, C.L., Wong, A.K., Yuan, Y., Scheckel, C., Fak, J.J., Funk, J., Yao, K., 
Tajima, Y., et al. (2019). Whole-genome deep-learning analysis identifies contribution of noncoding 
mutations to autism risk. Nat Genet 51, 973-980. 
18. Allen, F., Crepaldi, L., Alsinet, C., Strong, A.J., Kleshchevnikov, V., De Angeli, P., Páleníková, P., 
Khodak, A., Kiselev, V., Kosicki, M., et al. (2018). Predicting the mutations generated by repair of Cas9-
induced double-strand breaks. Nat Biotechnol 37, 64. 
19. Shen, M.W., Arbab, M., Hsu, J.Y., Worstell, D., Culbertson, S.J., Krabbe, O., Cassa, C.A., Liu, D.R., 
Gifford, D.K., and Sherwood, R.I. (2018). Predictable and precise template-free CRISPR editing of 
pathogenic variants. Nature 563, 646-651. 
20. Bailey, M.H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., 
Wendl, M.C., Kim, J., Reardon, B., et al. (2018). Comprehensive Characterization of Cancer Driver 
Genes and Mutations. Cell 174, 1034-1035. 
21. Luo, P., Ding, Y., Lei, X., and Wu, F.-X. (2019). deepDriver: Predicting Cancer Driver Genes Based on 
Somatic Mutations Using Deep Convolutional Neural Networks. Frontiers in genetics 10. 
22. Coudray, N., Ocampo, P.S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A.L., 
Razavian, N., and Tsirigos, A. (2018). Classification and mutation prediction from non–small cell lung 
cancer histopathology images using deep learning. Nat Med 24, 1559-1567. 
23. Tokheim, C.J., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., and Karchin, R. (2016). Evaluating the 
evaluation of cancer driver genes. Proc Natl Acad Sci U S A 113, 14330-14335. 
24. Uppu, S., Krishna, A., and Gopalan, R.P. (2018). A review on methods for detecting SNP interactions in 
high-dimensional genomic data. IEEE/ACM transactions on computational biology and bioinformatics 15, 
599-612. 
25. Kothen-Hill, S.T., Zviran, A., Schulman, R.C., Deochand, S., Gaiti, F., Maloney, D., Huang, K.Y., Liao, 
W., Robine, N., and Omans, N.D. (2018). Deep learning mutation prediction enables early stage lung 
cancer detection in liquid biopsy. 
26. Sanchez-Garcia, F., Villagrasa, P., Matsui, J., Kotliar, D., Castro, V., Akavia, U.D., Chen, B.J., Saucedo-
Cuevas, L., Rodriguez Barrueco, R., Llobet-Navas, D., et al. (2014). Integration of genomic data enables 
selective discovery of breast cancer drivers. Cell 159, 1461-1475. 
27. Ma, J., Sheridan, R.P., Liaw, A., Dahl, G.E., and Svetnik, V. (2015). Deep Neural Nets as a Method for 
Quantitative Structure–Activity Relationships. Journal of Chemical Information and Modeling 55, 263-
274. 
28. Unterthiner, T., Mayr, A., Klambauer, G., Steijaert, M., Wegner, J.K., Ceulemans, H., and Hochreiter, S. 
(2014). Deep learning as an opportunity in virtual screening. In Proceedings of the deep learning 
workshop at NIPS, Volume 27. pp. 1-9. 
29. Wallach, I., Dzamba, M., and Heifets, A. (2015). AtomNet: a deep convolutional neural network for 
bioactivity prediction in structure-based drug discovery. arXiv preprint arXiv:1510.02855. 
30. Zhavoronkov, A., Ivanenkov, Y.A., Aliper, A., Veselov, M.S., Aladinskiy, V.A., Aladinskaya, A.V., 
Terentiev, V.A., Polykovskiy, D.A., Kuznetsov, M.D., Asadulaev, A., et al. (2019). Deep learning enables 
rapid identification of potent DDR1 kinase inhibitors. Nat Biotechnol 37, 1038-1040. 
31. Kadurin, A., Nikolenko, S., Khrabrov, K., Aliper, A., and Zhavoronkov, A. (2017). druGAN: an advanced 
generative adversarial autoencoder model for de novo generation of new molecules with desired 
molecular properties in silico. Molecular pharmaceutics 14, 3098-3104. 
32. Merk, D., Friedrich, L., Grisoni, F., and Schneider, G. (2018). De novo design of bioactive small 
molecules by artificial intelligence. Molecular informatics 37, 1700153. 
33. Merk, D., Grisoni, F., Friedrich, L., and Schneider, G. (2018). Tuning artificial intelligence on the de novo 
design of natural-product-inspired retinoid X receptor modulators. Communications Chemistry 1, 68. 
34. Gómez-Bombarelli, R., Wei, J.N., Duvenaud, D., Hernández-Lobato, J.M., Sánchez-Lengeling, B., 
Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T.D., Adams, R.P., and Aspuru-Guzik, A. (2018). 
Automatic chemical design using a data-driven continuous representation of molecules. ACS central 
science 4, 268-276. 
35. Stokes, J.M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N.M., MacNair, C.R., French, 
S., Carfrae, L.A., Bloom-Ackerman, Z., et al. (2020). A Deep Learning Approach to Antibiotic Discovery. 
Cell 180, 688-702 e613. 
36. Evans, R., Jumper, J., Kirkpatrick, J., Sifre, L., Green, T., Qin, C., Zidek, A., Nelson, A., Bridgland, A., 
and Penedones, H. (2018). De Novo structure prediction with deep-learning based scoring. Thirteenth 
Critical Assessment of Techniques for Protein Structure Prediction (Abstracts). 
37. Hou, J., Wu, T., Cao, R., and Cheng, J. (2019). Protein tertiary structure modeling driven by deep 
learning and contact distance prediction in CASP13. BioRxiv, 552422. 
38. Silva, D.A., Yu, S., Ulge, U.Y., Spangler, J.B., Jude, K.M., Labao-Almeida, C., Ali, L.R., Quijano-Rubio, 
A., Ruterbusch, M., Leung, I., et al. (2019). De novo design of potent and selective mimics of IL-2 and IL-
15. Nature 565, 186-191. 
39. Wang, J., Cao, H., Zhang, J.Z.H., and Qi, Y. (2018). Computational Protein Design with Deep Learning 
Neural Networks. Sci Rep-Uk 8, 6349. 
40. Merico, D., Spickett, C., O'Hara, M., Kakaradov, B., Deshwar, A., Fradkin, P., Gandhi, S., Gao, J., Grant, 
S., and Kron, K. (2019). ATP7B Variant c. 1934T> G p. Met645Arg Causes Wilson Disease by 


































                   













    
 
- Improvement (by conv. ML) of 
polygenic risk scores (based on 
GWAS) [3-6] 
- Interaction of SNPs from GWAS 





Patient and disease 
categorization 
Diagnosis (eg, liquid biopsies) 
 
Identification / prediction of 
causal (functional) variants 
(and driver mutations in cancer 
NGS data on biopsis  
 
Identification of (drug) target 
molecules
 
Lead identification  / 
optimization Drug discovery 
Prediction of molecular 
properties 
in silico screening  of lead/drug 
candidates 
Functional data from genome-
wide genome editing screens 
Design of Genome editing tools 
(gRNA) 
Prediction NHEJ mutations 
            
       Genome editing (somatic) 
Gene- and cell-based therapies 
Experimental evidence  
(i.e., directly supported by studies) 
 
(“Conventional”) machine learning (ML) or deep 




(i.e., not yet supported by studies) 
 
- DL-Prediction of variant effects on 
intermediate cellular processes [7-
9] 
- Identification / prediction of 
causal (functional) variants for 
diseases by DL [8-14] 
- Identification / prediction of 
driver mutations in cancer, conv. 
ML and DL  [15-18] [also NGS data on 
liquid biopsies by DL  [20], data from 
functional RNAi screens [21, 22]] 
 
Companies that already use 
corresponding approaches 
DNA phenotyping 
eg,  ancestry or BMI,  as part of direct-
to-consumer testing 
Forensic (human) DNA phenotyping  
eg,  age, ancestry,  eye color, facial 
features, hair color, height,  skin color  
  
- Functional data from genome-wide 
genome editing screens [z.B. [1] and 
refs. therein] 
- Design of Genome editing tools by DL 
(gRNA) [25, 26] 




Knowledge on causal 









































- ML-prediction of externally 
visible characteristics, eg, height 
[2], age [23, 24] (also using DL 
[29]) , eye, hair and skin color 
[30, 31], ancestry [32] or facial 
features  [33, 34], from DNA 




Lead identification  / 
optimization Drug discovery 
Prediction of molecular 
properties 
in silico screening  of lead/drug 
candidates 
Functional data from genome-
wide genome editing screens 
Design of Genome editing tools 
(gRNA) 
Prediction NHEJ mutations 
            
       Genome editing (somatic) 
Gene- and cell-based therapies 
References 
1. Hart, T., Chandrashekhar, M., Aregger, M., Steinhart, Z., Brown, K.R., MacLeod, G., Mis, M., 
Zimmermann, M., Fradet-Turcotte, A., Sun, S., et al. (2015). High-Resolution CRISPR Screens Reveal 
Fitness Genes and Genotype-Specific Cancer Liabilities. Cell 163, 1515-1526. 
2. Lello, L., Avery, S.G., Tellier, L., Vazquez, A.I., de Los Campos, G., and Hsu, S.D.H. (2018). Accurate 
Genomic Prediction of Human Height. Genetics 210, 477-497. 
3. Khera, A.V., Chaffin, M., Aragam, K.G., Haas, M.E., Roselli, C., Choi, S.H., Natarajan, P., Lander, E.S., 
Lubitz, S.A., Ellinor, P.T., et al. (2018). Genome-wide polygenic scores for common diseases identify 
individuals with risk equivalent to monogenic mutations. Nat Genet 50, 1219–1224  
4. Lello, L., Raben, T.G., Yong, S.Y., Tellier, L.C., and Hsu, S.D. (2019). Genomic Prediction of Complex 
Disease Risk. BioRxiv, 506600. 
5. So, H.C., and Sham, P.C. (2017). Improving polygenic risk prediction from summary statistics by an 
empirical Bayes approach. Sci Rep-Uk 7. 
6. Paré, G., Mao, S., and Deng, W.Q. (2017). A machine-learning heuristic to improve gene score 
prediction of polygenic traits. Sci Rep-Uk 7, 12665. 
7. Alipanahi, B., Delong, A., Weirauch, M.T., and Frey, B.J. (2015). Predicting the sequence specificities of 
DNA- and RNA-binding proteins by deep learning. Nat Biotechnol 33, 831-+. 
8. Xiong, H.Y., Alipanahi, B., Lee, L.J., Bretschneider, H., Merico, D., Yuen, R.K.C., Hua, Y.M., 
Gueroussov, S., Najafabadi, H.S., Hughes, T.R., et al. (2015). The human splicing code reveals new 
insights into the genetic determinants of disease. Science 347. 
9. Jaganathan, K., Kyriazopoulou Panagiotopoulou, S., McRae, J.F., Darbandi, S.F., Knowles, D., Li, Y.I., 
Kosmicki, J.A., Arbelaez, J., Cui, W., Schwartz, G.B., et al. (2019). Predicting Splicing from Primary 
Sequence with Deep Learning. Cell 176, 535-548 e524. 
10. Zhou, J., and Troyanskaya, O.G. (2015). Predicting effects of noncoding variants with deep learning-
based sequence model. Nat Methods 12, 931-934. 
11. Zhou, J., Theesfeld, C.L., Yao, K., Chen, K.M., Wong, A.K., and Troyanskaya, O.G. (2018). Deep 
learning sequence-based ab initio prediction of variant effects on expression and disease risk. Nat Genet 
50, 1171-1179. 
12. Yao, V., Kaletsky, R., Keyes, W., Mor, D.E., Wong, A.K., Sohrabi, S., Murphy, C.T., and Troyanskaya, 
O.G. (2018). An integrative tissue-network approach to identify and test human disease genes. Nat 
Biotechnol 36, 1091–1099. 
13. Krishnan, A., Zhang, R., Yao, V., Theesfeld, C.L., Wong, A.K., Tadych, A., Volfovsky, N., Packer, A., 
Lash, A., and Troyanskaya, O.G. (2016). Genome-wide prediction and functional characterization of the 
genetic basis of autism spectrum disorder. Nat Neurosci 19, 1454-1462. 
14. Wang, D., Liu, S., Warrell, J., Won, H., Shi, X., Navarro, F.C.P., Clarke, D., Gu, M., Emani, P., Yang, 
Y.T., et al. (2018). Comprehensive functional genomic resource and integrative model for the human 
brain. Science 362. 
15. Bailey, M.H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., 
Wendl, M.C., Kim, J., Reardon, B., et al. (2018). Comprehensive Characterization of Cancer Driver 
Genes and Mutations. Cell 174, 1034-1035. 
16. Luo, P., Ding, Y., Lei, X., and Wu, F.-X. (2019). deepDriver: Predicting Cancer Driver Genes Based on 
Somatic Mutations Using Deep Convolutional Neural Networks. Frontiers in genetics 10. 
17. Coudray, N., Ocampo, P.S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A.L., 
Razavian, N., and Tsirigos, A. (2018). Classification and mutation prediction from non–small cell lung 
cancer histopathology images using deep learning. Nat Med 24, 1559-1567. 
18. Tokheim, C.J., Papadopoulos, N., Kinzler, K.W., Vogelstein, B., and Karchin, R. (2016). Evaluating the 
evaluation of cancer driver genes. Proc Natl Acad Sci U S A 113, 14330-14335. 
19. Uppu, S., Krishna, A., and Gopalan, R.P. (2018). A review on methods for detecting SNP interactions in 
high-dimensional genomic data. IEEE/ACM transactions on computational biology and bioinformatics 15, 
599-612. 
20. Kothen-Hill, S.T., Zviran, A., Schulman, R.C., Deochand, S., Gaiti, F., Maloney, D., Huang, K.Y., Liao, 
W., Robine, N., and Omans, N.D. (2018). Deep learning mutation prediction enables early stage lung 
cancer detection in liquid biopsy. 
21. Sanchez-Garcia, F., Villagrasa, P., Matsui, J., Kotliar, D., Castro, V., Akavia, U.D., Chen, B.J., Saucedo-
Cuevas, L., Rodriguez Barrueco, R., Llobet-Navas, D., et al. (2014). Integration of genomic data enables 
selective discovery of breast cancer drivers. Cell 159, 1461-1475. 
22. Pechal, J.L., Crippen, T.L., Tarone, A.M., Lewis, A.J., Tomberlin, J.K., and Benbow, M.E. (2013). 
Microbial community functional change during vertebrate carrion decomposition. PloS one 8, e79035. 
23. Hong, S.R., Jung, S.-E., Lee, E.H., Shin, K.-J., Yang, W.I., and Lee, H.Y. (2017). DNA methylation-
based age prediction from saliva: high age predictability by combination of 7 CpG markers. Forensic 
Science International: Genetics 29, 118-125. 
24. Aliferi, A., Ballard, D., Gallidabino, M.D., Thurtle, H., Barron, L., and Court, D.S. (2018). DNA 
methylation-based age prediction using massively parallel sequencing data and multiple machine 
learning models. Forensic Science International: Genetics 37, 215-226. 
25. Listgarten, J., Weinstein, M., Kleinstiver, B.P., Sousa, A.A., Joung, J.K., Crawford, J., Gao, K., Hoang, 
L., Elibol, M., and Doench, J.G. (2018). Prediction of off-target activities for the end-to-end design of 
CRISPR guide RNAs. Nature Biomedical Engineering 2, 38. 
26. Kim, H.K., Min, S., Song, M., Jung, S., Choi, J.W., Kim, Y., Lee, S., Yoon, S., and Kim, H.H. (2018). 
Deep learning improves prediction of CRISPR–Cpf1 guide RNA activity. Nat Biotechnol 36, 239. 
27. Allen, F., Crepaldi, L., Alsinet, C., Strong, A.J., Kleshchevnikov, V., De Angeli, P., Páleníková, P., 
Khodak, A., Kiselev, V., Kosicki, M., et al. (2018). Predicting the mutations generated by repair of Cas9-
induced double-strand breaks. Nat Biotechnol 37, 64. 
28. Shen, M.W., Arbab, M., Hsu, J.Y., Worstell, D., Culbertson, S.J., Krabbe, O., Cassa, C.A., Liu, D.R., 
Gifford, D.K., and Sherwood, R.I. (2018). Predictable and precise template-free CRISPR editing of 
pathogenic variants. Nature 563, 646-651. 
29. Vidaki, A., Ballard, D., Aliferi, A., Miller, T.H., Barron, L.P., and Court, D.S. (2017). DNA methylation-
based forensic age prediction using artificial neural networks and next generation sequencing. Forensic 
Science International: Genetics 28, 225-236. 
30. Walsh, S., Liu, F., Wollstein, A., Kovatsi, L., Ralf, A., Kosiniak-Kamysz, A., Branicki, W., and Kayser, M. 
(2013). The HIrisPlex system for simultaneous prediction of hair and eye colour from DNA. Forensic 
Science International: Genetics 7, 98-115. 
31. Chaitanya, L., Breslin, K., Zuñiga, S., Wirken, L., Pośpiech, E., Kukla-Bartoszek, M., Sijen, T., de Knijff, 
P., Liu, F., and Branicki, W. (2018). The HIrisPlex-S system for eye, hair and skin colour prediction from 
DNA: Introduction and forensic developmental validation. Forensic Science International: Genetics 35, 
123-135. 
32. Pereira, L., Alshamali, F., Andreassen, R., Ballard, R., Chantratita, W., Cho, N.S., Coudray, C., 
Dugoujon, J.-M., Espinoza, M., and González-Andrade, F. (2011). PopAffiliator: online calculator for 
individual affiliation to a major population group based on 17 autosomal short tandem repeat genotype 
profile. International journal of legal medicine 125, 629-636. 
33. Lippert, C., Sabatini, R., Maher, M.C., Kang, E.Y., Lee, S., Arikan, O., Harley, A., Bernal, A., Garst, P., 
Lavrenko, V., et al. (2017). Identification of individuals by trait prediction using whole-genome 
sequencing data. Proceedings of the National Academy of Sciences 114, 10166-10171. 
34. Sero, D., Zaidi, A., Li, J., White, J.D., Zarzar, T.B.G., Marazita, M.L., Weinberg, S.M., Suetens, P., 
Vandermeulen, D., Wagner, J.K., et al. (2019). Facial recognition from DNA using face-to-DNA 






































                   



















- ML for identification and analyses of 
pathogenic protein contents / 
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- ML for predicting novel bacterial 
pathogens from raw next generation 
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- DL for viral host prediction based on viral 
genome sequences  [18]   
 
 
Lead identification  / optimization Drug 
discovery 
Prediction of molecular properties 
in silico screening  of lead/drug candidates 
Functional data from genome-wide genome 
editing screens 
Design of Genome editing tools (gRNA) 
Prediction NHEJ mutations 
            
       Genome editing (somatic) 
Gene- and cell-based therapies 
Identification of virals sequences 
in human samples 
Analyzing or predicting antibiotic 
resistance in clinical and environmental 
samples 
 
Identifying or predicting the 
pathogenic potential of bacteria 
 
Microbiome forensics  
(eg, human  microbiome analyses to assess 
how long a murder victim has been dead; or to 
identify individuals) 
 
- DL for  Identification of viruses in 
metagenomic sequences  from human 
samples [5, 6] 
- ML for prediction of postmortem 
intervals from human microbiomes 
[1-4] 
 - ML for human identification via 








Experimental evidence  
(i.e., directly supported by studies) 
 
(“Conventional”) machine learning (ML) or deep 
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